BioCentury
ARTICLE | Product Development

Lupus makes leaps with three good pieces of news

Positive data on three different mechanism provides hope in SLE

November 15, 2019 2:54 AM UTC
Updated on Nov 15, 2019 at 2:56 AM UTC

The lupus community gets its first break in a long while with three products showing efficacy in late-stage trials for systemic lupus erythematosis.

That is welcome news in a disease that saw seven compounds fail to meet primary endpoints in Phase II or Phase III trails last year, and where only one new therapy has been approved in the past 60 years (see “Target Wide, Test Narrow in Lupus”)...

BCIQ Company Profiles

RemeGen Co. Ltd.